Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)

PHASE4TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

Insulin Glargine

For the control group (following the physician's standard practice) a minimum of 4 visits to the clinic is required. Insulin titration and concomitant medications will be done at the discretion of the physician. Strips will be distributed among patients in this group, but there will not be a requirement in frequency or type of SMBG.

DRUG

Insulin Glargine

"In the group following the algorithm, fasting SMBG will be asked 3 times a week until FBG\<100 mg/dl is achieved. Afterwards, 1 fasting SMBG will be asked weekly. Pre-prandial SMBG will be performed at the discretion of the physician.~For the group following the algorithm, during the titration period, weekly telephone contacts will be required and a minimum of 4 visits to the clinic."

Trial Locations (1)

Unknown

Sanofi-aventis administrative office Argentina, Buenos Aires

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY